Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea.

Lee H, Unemo M, Kim HJ, Seo Y, Lee K, Chong Y.

J Antimicrob Chemother. 2015 Jun 17. pii: dkv146. [Epub ahead of print]

PMID:
26084303
2.

Gonorrhea Treatment Failures With Oral and Injectable Expanded Spectrum Cephalosporin Monotherapy vs Dual Therapy at 4 Canadian Sexually Transmitted Infection Clinics, 2010-2013.

Singh AE, Gratrix J, Martin I, Friedman DS, Hoang L, Lester R, Metz G, Ogilvie G, Read R, Wong T.

Sex Transm Dis. 2015 Jun;42(6):331-6. doi: 10.1097/OLQ.0000000000000280.

PMID:
25970311
3.

Will use of combination cephalosporin/azithromycin therapy forestall resistance to cephalosporins in Neisseria gonorrhoeae?

Rice LB.

Sex Transm Infect. 2015 Jun;91(4):238-40. doi: 10.1136/sextrans-2014-051730. Epub 2015 Apr 29. No abstract available.

PMID:
25926405
5.

Antimicrobial susceptibility and typing of Neisseria gonorrhoeae strains from Southern Spain, 2012-2014.

Cobo F, Cabezas-Fernández MT, Cabeza-Barrera MI.

Enferm Infecc Microbiol Clin. 2015 Feb 27. pii: S0213-005X(15)00066-X. doi: 10.1016/j.eimc.2015.01.017. [Epub ahead of print]

PMID:
25735717
6.

Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution.

Wind CM, de Vries HJ, van Dam AP.

Int J Antimicrob Agents. 2015 Mar;45(3):305-8. doi: 10.1016/j.ijantimicag.2014.10.020. Epub 2014 Dec 2.

PMID:
25532741
7.

Gonorrhea treatment practices in the STD Surveillance Network, 2010-2012.

Kerani RP, Stenger MR, Weinstock H, Bernstein KT, Reed M, Schumacher C, Samuel MC, Eaglin M, Golden M.

Sex Transm Dis. 2015 Jan;42(1):6-12. doi: 10.1097/OLQ.0000000000000217.

PMID:
25504294
8.

Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.

Cole MJ, Spiteri G, Chisholm SA, Hoffmann S, Ison CA, Unemo M, Van de Laar M.

Euro Surveill. 2014 Nov 13;19(45):20955.

9.

Evaluation of gonorrhea test of cure at 1 week in a Los Angeles community-based clinic serving men who have sex with men.

Beymer MR, Llata E, Stirland AM, Weinstock HS, Wigen CL, Guerry SL, Mejia E, Bolan RK.

Sex Transm Dis. 2014 Oct;41(10):595-600. doi: 10.1097/OLQ.0000000000000190. Erratum in: Sex Transm Dis. 2015 Jun;42(6):350.

PMID:
25211254
10.

In vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against MDR clinical Neisseria gonorrhoeae isolates and international reference strains.

Jacobsson S, Golparian D, Phan LT, Ohnishi M, Fredlund H, Or YS, Unemo M.

J Antimicrob Chemother. 2015 Jan;70(1):173-7. doi: 10.1093/jac/dku344. Epub 2014 Sep 1.

PMID:
25182063
11.

Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary.

Brunner A, Nemes-Nikodem E, Mihalik N, Marschalko M, Karpati S, Ostorhazi E.

BMC Infect Dis. 2014 Aug 6;14:433. doi: 10.1186/1471-2334-14-433.

12.

Surveillance of antimicrobial susceptibilities of Neisseria gonorrhoeae in Nanning, China, 2000 to 2012.

Zhu BY, Yu RX, Yin Y, Chen X, Li W, Dai XQ, Liang M, Gan Q, Huang YJ, Wei JP.

Sex Transm Dis. 2014 Aug;41(8):501-6. doi: 10.1097/OLQ.0000000000000157.

PMID:
25013979
13.

Antimicrobial resistance, genetic resistance determinants for ceftriaxone and molecular epidemiology of Neisseria gonorrhoeae isolates in Nanjing, China.

Chen SC, Yin YP, Dai XQ, Unemo M, Chen XS.

J Antimicrob Chemother. 2014 Nov;69(11):2959-65. doi: 10.1093/jac/dku245. Epub 2014 Jul 9.

PMID:
25011655
14.

Gonorrhoea in 21st century--international and Polish situation.

Serwin AB, Koper M, Unemo M.

Przegl Epidemiol. 2014;68(1):39-44, 127-31. English, Polish. Erratum in: Przegl Epidemiol. 2014;68(2):322.

15.

Neisseria gonorrhoeae strain with reduced susceptibilities to extended-spectrum cephalosporins.

Nguyen D, Gose S, Castro L, Chung K, Bernstein K, Samuel M, Bauer H, Pandori M.

Emerg Infect Dis. 2014 Jul;20(7):1211-3. doi: 10.3201/eid2007.131396.

16.

Russian gonococcal antimicrobial susceptibility programme (RU-GASP)--resistance in Neisseria gonorrhoeae during 2009-2012 and NG-MAST genotypes in 2011 and 2012.

Kubanova A, Kubanov A, Frigo N, Solomka V, Semina V, Vorobyev D, Khairullin R, Unemo M.

BMC Infect Dis. 2014 Jun 19;14:342. doi: 10.1186/1471-2334-14-342.

17.

Treatment of gonococcal infection: when one drug is not enough.

Kransdorf LN, Kling JM, Mayer AP.

J Womens Health (Larchmt). 2014 Jul;23(7):627-8. doi: 10.1089/jwh.2014.4820. Epub 2014 Jun 11. No abstract available.

PMID:
24918549
18.

Comparison of two Gram stain point-of-care systems for urogenital gonorrhoea among high-risk patients: diagnostic accuracy and cost-effectiveness before and after changing the screening algorithm at an STI clinic in Amsterdam.

Bartelsman M, Straetemans M, Vaughan K, Alba S, van Rooijen MS, Faber WR, de Vries HJ.

Sex Transm Infect. 2014 Aug;90(5):358-62. doi: 10.1136/sextrans-2013-051500. Epub 2014 May 23.

PMID:
24860102
19.

Antimicrobial susceptibility and molecular epidemiology of Neisseria gonorrhoeae in Germany.

Horn NN, Kresken M, Körber-Irrgang B, Göttig S, Wichelhaus C, Wichelhaus TA; Working Party Antimicrobial Resistance of the Paul Ehrlich Society for Chemotherapy.

Int J Med Microbiol. 2014 Jul;304(5-6):586-91. doi: 10.1016/j.ijmm.2014.04.001. Epub 2014 Apr 19.

PMID:
24801146
20.

Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.

Morita-Ishihara T, Unemo M, Furubayashi K, Kawahata T, Shimuta K, Nakayama S, Ohnishi M.

J Antimicrob Chemother. 2014 Aug;69(8):2086-90. doi: 10.1093/jac/dku118. Epub 2014 Apr 28.

PMID:
24777907
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk